MPWT
RAPP

MassMutual Private Wealth & Trust’s Rapport Therapeutics RAPP Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.79K Hold
163
– – ﹤0.01% 1568
2026
Q1 		$5.1K Buy
163
+2
+1% +$56 ﹤0.01% 1669
2025
Q4 		$4.88K Buy
+161
New +$4.46K ﹤0.01% 1681

Other funds holding RAPP

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust's RAPP Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Rapport Therapeutics (RAPP) position steady in Q2 2026 at 163 shares worth $6.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

MassMutual Private Wealth & Trust first reported a position in RAPP in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold RAPP as of Q2 2026.

  • MassMutual Private Wealth & Trust held 163 shares of Rapport Therapeutics worth $6.79K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Rapport Therapeutics share count unchanged in Q2 2026.
  • Rapport Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1568 holding.
  • MassMutual Private Wealth & Trust first reported a position in Rapport Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 8 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.